Fundsmith LLP Boosts Stock Holdings in The Clorox Company $CLX

Fundsmith LLP increased its position in The Clorox Company (NYSE:CLXFree Report) by 5.5% in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 271,318 shares of the company’s stock after acquiring an additional 14,101 shares during the period. Clorox comprises approximately 0.2% of Fundsmith LLP’s holdings, making the stock its 29th largest position. Fundsmith LLP’s holdings in Clorox were worth $25,895,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently modified their holdings of CLX. BlackRock Inc. purchased a new position in Clorox in the 2nd quarter worth about $958,640,000. Bank of America Corp DE bought a new stake in shares of Clorox in the second quarter worth approximately $179,780,000. Norges Bank bought a new stake in shares of Clorox in the fourth quarter worth approximately $135,735,000. Bank of New York Mellon Corp purchased a new position in shares of Clorox during the second quarter valued at approximately $123,154,000. Finally, Equity Investment Corp bought a new position in Clorox during the second quarter valued at approximately $111,800,000. 78.53% of the stock is owned by institutional investors.

Clorox Stock Performance

NYSE:CLX opened at $102.57 on Monday. The company has a debt-to-equity ratio of 15.80, a quick ratio of 0.38 and a current ratio of 0.66. The stock has a 50-day simple moving average of $99.83 and a two-hundred day simple moving average of $102.60. The firm has a market capitalization of $12.40 billion, a PE ratio of 21.28, a P/E/G ratio of 3.21 and a beta of 0.54. The Clorox Company has a 52-week low of $84.70 and a 52-week high of $128.90.

Clorox (NYSE:CLXGet Free Report) last posted its quarterly earnings data on Monday, August 3rd. The company reported $1.66 earnings per share for the quarter, beating analysts’ consensus estimates of $1.64 by $0.02. The firm had revenue of $1.95 billion for the quarter, compared to analysts’ expectations of $1.91 billion. Clorox had a return on equity of 522.23% and a net margin of 8.74%.The business’s quarterly revenue was down 2.0% on a year-over-year basis. During the same period in the previous year, the firm earned $2.87 EPS. Clorox has set its FY 2027 guidance at 5.700-6.000 EPS. Analysts forecast that The Clorox Company will post 5.8 EPS for the current year.

Clorox Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, August 28th. Shareholders of record on Wednesday, August 12th were given a $1.25 dividend. The ex-dividend date was Wednesday, August 12th. This is an increase from Clorox’s previous quarterly dividend of $1.24. This represents a $5.00 dividend on an annualized basis and a dividend yield of 4.9%. Clorox’s dividend payout ratio (DPR) is currently 103.73%.

Analyst Ratings Changes

A number of equities research analysts have commented on CLX shares. Citigroup lifted their target price on shares of Clorox from $97.00 to $100.00 and gave the stock a “neutral” rating in a research report on Tuesday, August 4th. BNP Paribas Exane dropped their price target on Clorox from $97.00 to $95.00 and set a “neutral” rating on the stock in a research note on Monday, July 20th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Clorox in a report on Friday, July 10th. Evercore set a $99.00 price objective on Clorox in a research report on Tuesday, August 4th. Finally, UBS Group raised their target price on Clorox from $100.00 to $105.00 and gave the stock a “neutral” rating in a research report on Tuesday, August 4th. Twelve equities research analysts have rated the stock with a Hold rating and five have issued a Sell rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Reduce” and an average target price of $102.40.

Read Our Latest Stock Analysis on Clorox

Clorox Company Profile

(Free Report)

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.

Recommended Stories

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.